A. McLean

Therapeutic targets in triple negative breast cancer

S. O'toole, E. Millar, A. Swarbrick, 2013, Journal of Clinical Pathology.

Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinic

T. Corte, M. Fry, P. Torzillo, 2020, Respirology.

Blowing Away Fatty Liver: Mission Impossible?

B. Yee, A. McLean, F. Gagnadoux, 2020, American journal of respiratory and critical care medicine.

Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C.

A. McLean, V. Ho, S. Terry, 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

PDl1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome.

J. Madore, J. Wilmott, R. Scolyer, 2016, Pathology.

Programmed death ligand 1 expression in triple‐negative breast cancer is associated with tumour‐infiltrating lymphocytes and improved outcome

J. Madore, J. Wilmott, R. Scolyer, 2016, Histopathology.

Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients.

I. Hall, B. Lipworth, K. Tan, 1997, American journal of respiratory and critical care medicine.

The emerging role of the lung microbiome and its importance in non-small cell lung cancer diagnosis and treatment.

R. Scolyer, M. Kohonen-Corish, W. Cooper, 2022, Lung cancer.

Diagnosing Lung Cancer: The Complexities of Obtaining a Tissue Diagnosis in the Era of Minimally Invasive and Personalised Medicine

A. McLean, D. Barnes, L. Troy, 2018, Journal of clinical medicine.

Severe Systemic Lupus Erythematosus Induced by Antiviral Treatment for Hepatitis C: 486

A. McLean, V. Ho, S. Terry, 2007 .